Who
Mohamed Khairie Issa
EVP, Head of U.S. Commercial
Company insider
Files Form 4 as: EVP, Head of U.S. Commercial, Incyte.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $2.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Jan 2025
- Last trade
- 16 Jul 2026
- Last filed
- 20 Jul 2026
Companies traded
Activity over time
1 Jan – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jul 2026filed 20 Jul 2026 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $126K1,093 at $115.01 | filing |
| 16 Jul 2026filed 20 Jul 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —7,857 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —19,643 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —19,643 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —33,918 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —33,918 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $126K1,093 at $115.01 | filing |
| 16 Jul 2026filed 20 Jul 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —7,857 at $0.00 | filing |
| 15 Jul 2026filed 16 Jul 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $126K1,099 at $115.09 | filing |
| 15 Jul 2026filed 16 Jul 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $126K1,099 at $115.09 | filing |
| 16 Jan 2026filed 21 Jan 2026 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —14,237 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —14,237 at $0.00 | filing |
| 7 Jan 2026filed 8 Jan 2026 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $1.2M10,856 at $109.07 | filing |
| 7 Jan 2026filed 8 Jan 2026 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $1.2M10,856 at $109.07 | filing |
| 6 Jan 2026filed 8 Jan 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $881K8,264 at $106.66 | filing |
| 6 Jan 2026filed 8 Jan 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $881K8,264 at $106.66 | filing |
| 15 Jul 2025filed 17 Jul 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —21,923 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —19,735 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —8,769 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —27,812 at $0.00 | filing |
News
Comparing Madrigal Pharmaceuticals (NASDAQ:MDGL) and Incyte (NASDAQ:INCY)INCY · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Mohamed Khairie Issa; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.